ClinicalTrials.Veeva

Menu
C

Cone Health | Regional Center for Infectious Disease (RCID)

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Diroximel Fumarate
Rovalpituzumab
Inclisiran
Diuretic

Parent organization

This site is a part of Cone Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 21 total trials

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure (ALLEVIATE-HF)

The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal...

Active, not recruiting
Heart Failure NYHA Class II
Heart Failure NYHA Class III
Device: Reveal LINQâ„¢ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download
Other: Medication intervention

The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therap...

Active, not recruiting
Heart Failure
Device: BAROSTIM NEO® System
Drug: Medical Management

RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to...

Active, not recruiting
Hypertension
Hypertension, Resistant to Conventional Therapy
Device: Renal Denervation

VictORION-INCLUSION (V-INCLUSION) seeks to evaluate the effectiveness of inclisiran as an innovative therapy with the potential to help bridge care g...

Enrolling
Atherosclerotic Cardiovascular Disease
Drug: Inclisiran

Trial sponsors

Medtronic logo
C
Amgen logo
A
AbbVie logo
Biogen logo
Duke University logo
Masimo logo
NYU Langone Health logo
ReCor Medical logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems